Does OSIMERTINIB Cause Pulmonary embolism? 254 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 254 reports of Pulmonary embolism have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.9% of all adverse event reports for OSIMERTINIB.
254
Reports of Pulmonary embolism with OSIMERTINIB
0.9%
of all OSIMERTINIB reports
69
Deaths
121
Hospitalizations
How Dangerous Is Pulmonary embolism From OSIMERTINIB?
Of the 254 reports, 69 (27.2%) resulted in death, 121 (47.6%) required hospitalization, and 27 (10.6%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for OSIMERTINIB.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which OSIMERTINIB Alternatives Have Lower Pulmonary embolism Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN